\u4ee5\u5b9e\u73b0Presendin\u6cbb\u7597IIH\u7684\u5168\u7403\u6ce8\u518c\u3002<\/a><\/p>\nIIH EVOLVE\u8bd5\u9a8c\u5c06\u5728\u6b27\u6d32\u3001\u82f1\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u768437\u4e2a\u4e2d\u5fc3\u62db\u52df240\u540d\u60a3\u8005\uff0c\u968f\u673a\u63a5\u53d7Presendin\u6216\u5b89\u6170\u5242\u76ae\u4e0b\u6ce8\u5c04\uff0c\u6bcf\u5468\u6ce8\u5c04\u4e00\u6b21\uff0c\u6301\u7eed24\u5468\u3002<\/p>\n
\u4e3b\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u63a5\u53d7Presendin\u548c\u5b89\u6170\u5242\u7684\u60a3\u8005\u4ece\u57fa\u7ebf\u523024\u5468\u7684\u5e73\u5747\u9885\u5185\u538b\u5dee\u5f02\u3002<\/p>\n
\u6b21\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u4e24\u7ec424\u5468\u5185\u89c6\u529b\u7684\u76f8\u5bf9\u5dee\u5f02(\u79f0\u4e3a\u5468\u5e73\u5747\u504f\u5dee\u548c\u4e73\u5934\u6c34\u80bf)\u548c\u6bcf\u6708\u5934\u75db\u5929\u6570(MHD)\u3002<\/p>\n
\u4efb\u547d\u8bd5\u9a8c\u7763\u5bfc\u5c0f\u7ec4\u4e3b\u5e2d<\/h2>\n
\u4e0a\u5468\uff0cInvex\u5ba3\u5e03\u5df2\u4efb\u547dMichael Wall\u6559\u6388\u4e3aIIH EVOLVE\u8bd5\u9a8c\u7684\u8bd5\u9a8c\u6307\u5bfc\u5c0f\u7ec4\u4e3b\u5e2d\u3002<\/p>\n
Wall\u535a\u58eb\u662f\u7231\u8377\u534e\u5927\u5b66\u533b\u5b66\u9662\u773c\u79d1\u5b66\u548c\u795e\u7ecf\u5b66\u6559\u6388\uff0c\u7231\u8377\u534e\u89c6\u91ce\u9605\u8bfb\u4e2d\u5fc3\u4e3b\u4efb\u3002<\/p>\n
Invex\u6267\u884c\u8463\u4e8b\u517c\u9996\u5e2d\u79d1\u5b66\u5b98Alexandra Sinclair\u6559\u6388\u8bf4\uff0c\u6c83\u5c14\u6559\u6388\u201c\u5728IIH\u9886\u57df\u6709\u7740\u6770\u51fa\u7684\u804c\u4e1a\u751f\u6daf\uff0c\u5728\u795e\u7ecf\u75c5\u5b66\u548c\u773c\u79d1\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6267\u884c\u65b9\u9762\u62e5\u6709\u4e30\u5bcc\u7684\u7ecf\u9a8c\u548c\u4e13\u4e1a\u77e5\u8bc6\uff0c\u4e3a\u5236\u836f\u516c\u53f8\u5728\u7f8e\u56fd\u548c\u5168\u7403\u8fdb\u884c\u7814\u7a76\u3002<\/p>\n
Sinclair\u6559\u6388\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u5f53\u7136\u6b22\u8fce\u4e0eWall\u6559\u6388\u5728IIH\u91cd\u8981\u7684\u7b2c\u4e09\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u5408\u4f5c\u7684\u673a\u4f1a\uff0c\u5728\u8fd9\u4e00\u9636\u6bb5\u8fd8\u7f3a\u4e4f\u5f97\u5230\u6279\u51c6\u7684\u7597\u6cd5\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002 \u8fd9\u7b14\u56de\u6263\u6d89\u53ca\u5176\u5b50\u516c\u53f8Invex UK\u8fdb\u884c\u7684\u7814\u53d1\u6d3b\u52a8\uff0c\u5305\u62ec\u5176\u836f\u7269Presendin\u8ba1\u5212\u7684\u4e09\u671f\u4e34\u5e8a\u9879\u76ee\u7684\u524d\u671f\u7814\u7a76\u3002 Invex\u4e13\u6ce8\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316Presendin\uff0c\u7528\u4e8e\u4e0e\u9885\u5185\u538b\u5347\u9ad8\u76f8\u5173\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u7684\u6cbb\u7597\u3002 \u9000\u7a0e\u662f\u82f1\u56fd\u653f\u5e9c\u9f13\u52b1\u672c\u56fd\u521b\u65b0\u6295\u8d44\u6218\u7565\u7684\u4e00\u90e8\u5206\u3002Invex\u83b7\u5f97\u7684\u56de\u6263\u5360\u516c\u53f8\u5408\u683c\u7814\u53d1\u652f\u51fa\u768413%\u3002 Invex\u6267\u884c\u8463\u4e8bTom Duthy\u535a\u58eb\u8868\u793a\uff0c\u6536\u5230\u989d\u5916\u7684\u975e\u7a00\u91ca\u8d44\u91d1\u53cd\u6620\u4e86\u8be5\u516c\u53f8\u81f4\u529b\u4e8e\u6295\u8d44\u5176\u6838\u5fc3\u7814\u53d1\u8d44\u4ea7\uff0c\u7279\u522b\u662f\u5f00\u53d1\u7528\u4e8e\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u7684Presendin\u3002 \u201c\u6211\u4eec\u9884\u8ba1\u5728\u672a\u6765\u4e00\u6bb5\u65f6\u95f4\u5185\uff0c\u968f\u7740\u516c\u53f8\u52a0\u901f\u7814\u53d1\u652f\u51fa\uff0c\u4ee5\u652f\u6301\u6211\u4eec\u91cd\u8981\u7684\u6ce8\u518c\u6307\u5bfcIIH\u6f14\u5316\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6211\u4eec\u9884\u8ba1\u5c06\u5728\u82f1\u56fd\u3001\u6b27\u76df\u3001\u6fb3\u5927\u5229\u4e9a\u7b49\u5730\u62db\u52dfIIH\u60a3\u8005\uff0c\u82f1\u56fd\u8fd4\u5229\u5c06\u589e\u52a0\uff0c\u6fb3\u5927\u5229\u4e9a\u7814\u53d1\u9000\u7a0e\u4e5f\u5c06\u5f00\u59cb\u3002\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\uff0c\u201dDuthy\u535a\u58eb\u8bf4\u3002 \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c 11\u6708\u521d\uff0cInvex\u8bc1\u5b9e\u5c06\u7ee7\u7eed\u8fdb\u884c\u4e09\u671f\u8bd5\u9a8c\uff0c\u4ee5\u5b9e\u73b0Presendin\u6cbb\u7597IIH\u7684\u5168\u7403\u6ce8\u518c\u3002 IIH EVOLVE\u8bd5\u9a8c\u5c06\u5728\u6b27\u6d32\u3001\u82f1\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u768437\u4e2a\u4e2d\u5fc3\u62db\u52df240\u540d\u60a3\u8005\uff0c\u968f\u673a\u63a5\u53d7Presendin\u6216\u5b89\u6170\u5242\u76ae\u4e0b\u6ce8\u5c04\uff0c\u6bcf\u5468\u6ce8\u5c04\u4e00\u6b21\uff0c\u6301\u7eed24\u5468\u3002 \u4e3b\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u63a5\u53d7Presendin\u548c\u5b89\u6170\u5242\u7684\u60a3\u8005\u4ece\u57fa\u7ebf\u523024\u5468\u7684\u5e73\u5747\u9885\u5185\u538b\u5dee\u5f02\u3002 \u6b21\u8981\u7ec8\u70b9\u5c06\u8bc4\u4f30\u4e24\u7ec424\u5468\u5185\u89c6\u529b\u7684\u76f8\u5bf9\u5dee\u5f02(\u79f0\u4e3a\u5468\u5e73\u5747\u504f\u5dee\u548c\u4e73\u5934\u6c34\u80bf)\u548c\u6bcf\u6708\u5934\u75db\u5929\u6570(MHD)\u3002 \u4efb\u547d\u8bd5\u9a8c\u7763\u5bfc\u5c0f\u7ec4\u4e3b\u5e2d \u4e0a\u5468\uff0cInvex\u5ba3\u5e03\u5df2\u4efb\u547dMichael Wall\u6559\u6388\u4e3aIIH EVOLVE\u8bd5\u9a8c\u7684\u8bd5\u9a8c\u6307\u5bfc\u5c0f\u7ec4\u4e3b\u5e2d\u3002 Wall\u535a\u58eb\u662f\u7231\u8377\u534e\u5927\u5b66\u533b\u5b66\u9662\u773c\u79d1\u5b66\u548c\u795e\u7ecf\u5b66\u6559\u6388\uff0c\u7231\u8377\u534e\u89c6\u91ce\u9605\u8bfb\u4e2d\u5fc3\u4e3b\u4efb\u3002 Invex\u6267\u884c\u8463\u4e8b\u517c\u9996\u5e2d\u79d1\u5b66\u5b98Alexandra Sinclair\u6559\u6388\u8bf4\uff0c\u6c83\u5c14\u6559\u6388\u201c\u5728IIH\u9886\u57df\u6709\u7740\u6770\u51fa\u7684\u804c\u4e1a\u751f\u6daf\uff0c\u5728\u795e\u7ecf\u75c5\u5b66\u548c\u773c\u79d1\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6267\u884c\u65b9\u9762\u62e5\u6709\u4e30\u5bcc\u7684\u7ecf\u9a8c\u548c\u4e13\u4e1a\u77e5\u8bc6\uff0c\u4e3a\u5236\u836f\u516c\u53f8\u5728\u7f8e\u56fd\u548c\u5168\u7403\u8fdb\u884c\u7814\u7a76\u3002 Sinclair\u6559\u6388\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u5f53\u7136\u6b22\u8fce\u4e0eWall\u6559\u6388\u5728IIH\u91cd\u8981\u7684\u7b2c\u4e09\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u5408\u4f5c\u7684\u673a\u4f1a\uff0c\u5728\u8fd9\u4e00\u9636\u6bb5\u8fd8\u7f3a\u4e4f\u5f97\u5230\u6279\u51c6\u7684\u7597\u6cd5\u3002\u201d<\/p>\n","protected":false},"author":5,"featured_media":17989,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"\n
Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-20T06:49:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-UK-Presendin-receives-tax-rebate-neurological-drug-research.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/\",\"name\":\"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-12-20T06:49:26+00:00\",\"dateModified\":\"2023-08-29T18:01:41+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e","description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e","og_description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/","og_site_name":"smallcapsCN","article_published_time":"2021-12-20T06:49:26+00:00","article_modified_time":"2023-08-29T18:01:41+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-UK-Presendin-receives-tax-rebate-neurological-drug-research.jpg","type":"image\/jpeg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/","name":"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-12-20T06:49:26+00:00","dateModified":"2023-08-29T18:01:41+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u8fd1\u65e5\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4ece\u82f1\u56fd\u653f\u5e9c\u83b7\u5f97\u4e862021\u8d22\u5e74\u7ea610\u4e07\u82f1\u9551(18.6\u4e07\u6fb3\u5143)\u7684\u7814\u53d1\u9000\u7a0e\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-receives-tax-rebate-neurological-drug-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics\u83b7\u5f97\u795e\u7ecf\u836f\u7269\u7814\u7a76\u7684\u9000\u7a0e"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4423"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4423"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4423\/revisions"}],"predecessor-version":[{"id":14302,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4423\/revisions\/14302"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/17989"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}